| 11. Dr. Jones decides to buy stock in the pharmaceutical companies whose products he prefers and most frequently prescribes. |
| # | Response Date | Comment |
| 1. | Tue, 3/13/07 10:57 PM | as long as he prescribes it appropriately. |
| 2. | Tue, 3/13/07 11:09 PM | Dr. Jones should feel free to invest his money as he sees fit, so long as the reason that he prefers the products of the companies in which he invests is that those products truly best meet the needs of his patients. If not, a serious COI exists. |
| 3. | Tue, 3/13/07 11:29 PM | If the product has been shown to be the most effective then there is minimal conflict of interest vs. if the product is terrible. |
| 4. | Wed, 3/14/07 12:18 AM | On why he prescribes them and whether or not, if alternative therapy is indicated, his stock ownership would change his practice pattern. |
| 5. | Wed, 3/14/07 12:30 AM | It depends how much stock he buys and whether he allows his purchase to influence his medical practice. |
| 6. | Wed, 3/14/07 1:16 AM | If his prescription numbers for the particular product increase above his baseline, this is a serious conflict. |
| 7. | Wed, 3/14/07 1:58 AM | Depends on the amount of the purchase. |
| 8. | Wed, 3/14/07 3:47 AM | Depends on if his prescribing practices are determined by his stocks or stocks are determined by prescribing. (if this is the medication he feels is the best then purchases stock) |
| 9. | Wed, 3/14/07 12:14 PM | On his disclosures to patients and peers. |
| 10. | Wed, 3/14/07 1:53 PM | If he is prescribing because he prefers the drug--no COI. But if he prescribes because he owns stock, then a serious COI |
| 11. | Wed, 3/14/07 2:27 PM | If the individual purchases the individual stock, there may be potential for influence in practicing pattern...if the stock are purchased by someone else as part of mutual fund mgmt, I see less conflict |
| 12. | Wed, 3/14/07 10:04 PM | how much stock? |
| 13. | Fri, 3/16/07 11:29 AM | on if the perscribing habits change or if the purchase is becuase the company makes good products! |
| 14. | Mon, 3/19/07 1:46 PM | He needs to disclose this to his patients when prescribing them. |
| 15. | Mon, 3/19/07 4:17 PM | As long as the preferences are based on clinical evidence that is valid and improves care. Otherwise this is the American way. |
| 16. | Mon, 3/19/07 4:58 PM | This is a moderate COI and why public disclosure of COI Statements is good policy. |
| 17. | Mon, 3/19/07 5:30 PM | If that's the basis for the decision, then Dr. Jones is building into the practice a disincentive to prescribe otherwise. |
| 18. | Mon, 3/26/07 3:14 PM | makes me wonder what companies are in my mutual funds?
Doing so would lead to the appearance of changing practice specifically for financial gain, which would be a COI |
| 19. | Tue, 4/24/07 1:37 PM | If the doctor is not the head of a big PC or HMO that could actually alter the pharmaceutical's financial statement then I don't think there is a COI. Individual Dr.'s should be able to buy stock in a drug co. that they think has good products and could be a good investment. |
| 20. | Tue, 4/24/07 9:49 PM | I think its unreasonable to think the prescribing practice of one physician is capable of affecting the stock price or dividends distributions of an entire pharmaceutical company. So no. |
| 21. | Thu, 4/26/07 9:22 PM | A very serious COI if he actually buys the stock, after he decided to buy the stock. |
| 22. | Fri, 4/27/07 5:38 PM | This would be fine if the physician is not steering buisness away from competitors against sound medical evidence. |
| 23. | Tue, 5/8/07 3:29 PM | .... |